How Ethos Sold Wall Street on AI While Powering an Analog Boiler Room
Jenny Ahn, Michelle Cera, Ruth Reader, Hunterbrook
Vioxx
In August 2013, a federal judge preliminarily approved a $23 million settlement to a class-action lawsuit filed against Merck Sharp & Dohme Corp. for allegedly falsely advertising that Vioxx had greater benefits than the generic versions when these benefits had not been established. According to the settlement terms, class members may receive a cash award of up to $75 with proof of purchase. (In re: Vioxx Products Liability Litigation, MDL No. 1657, E. D. LA.).
The Latest
CATrends: Unscented Deodorants and Antiperspirants
Lawsuits allege marketing doesn’t pass the smell test.
HydroJug’s Heat-Retention Claims
Can these bottles really keep drinks hot for up to six hours?
With Personalized Pricing, Disclosure Is a Start, But Not a Finish Line
TINA.org and other consumer advocates file comment with FTC.
MLMs Are Consistently Leaving Participants Behind
New book explores why MLMs are often associated with harmful outcomes – and what can be done about it.